Adaptive Biotechnologies's total assets for Q2 2025 were $496.64M, a decrease of -2.78% from the previous quarter. ADPT total liabilities were $317.10M for the fiscal quarter, a -1.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.